This announcement is a separate document:
灵康药业：《关于请做好灵康药业集团股份有限公司公开发行可转换公司债券发审委会议准备工作的函》之回复报告（修订稿）
Lingkang Pharmaceutical: Response Report to the “Letter on Preparing for the Development and Review Committee Meeting on the Public Issuance of Convertible Corporate Bonds by Lingkang Pharmaceutical Group Co., Ltd.” (Revised Draft)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated